SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001607062-16-000655
Filing Date
2016-02-12
Accepted
2016-02-12 16:10:25
Documents
1
Period of Report
2016-02-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 brusegard021216form4.html 4  
1 FORM 4 brusegard021216form4.xml 4 13796
  Complete submission text file 0001607062-16-000655.txt   15179
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Issuer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4145 NORTH SERVICE ROAD, SUITE 200 BURLINGTON A6 L7L6A3
Business Address
Brusegard David (Reporting) CIK: 0001516920 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-25169 | Film No.: 161419139